Press release
Beta-Glucan Market Set for Steady Growth at 7.05% CAGR Through 2031, Led by Europe's Dominant 36.6% Market Share | DataM Intelligence
Beta-Glucan Market
Market growth is driven by rising demand for functional foods and nutraceuticals, increasing consumer awareness of immune-boosting and cholesterol-lowering benefits, and expanding applications in animal feed and cosmetics. Advancements in extraction technologies from sources like oats, yeast, and mushrooms, coupled with regulatory approvals for health claims and growing investments in sustainable sourcing, are further accelerating market expansion.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/beta-glucan-market?ram
Europe: Key Industry Developments
✅ November 2025: Tate & Lyle PLC launched an innovative soluble oat beta-glucan variant optimized for bakery applications, enhancing cholesterol-lowering claims under EFSA guidelines and targeting the clean-label trend in functional foods.
✅ September 2025: Kerry Group introduced a yeast-derived beta-glucan active for personalized nutrition supplements, focusing on immune support amid rising demand for plant-based health products in Germany and the UK.
✅ August 2025: DSM Nutritional Products expanded production of mushroom beta-glucan for pharmaceuticals, driven by R&D partnerships emphasizing sustainability and novel sources for cosmetics.
United States: Key Industry Developments
✅ November 2025: Tate & Lyle expanded its beta-glucan portfolio with a new high-solubility oat-derived variant for functional beverages, enhancing immune support claims amid rising demand for heart-healthy formulations.
✅ September 2025: Kerry Group launched beta-glucan-infused skincare actives targeting hydration and barrier repair, capturing 45% of the soothing formulations market in premium dermo-cosmetics.
✅ August 2025: Kemin Industries introduced a yeast beta-glucan supplement line for immune modulation, supported by clinical data on cholesterol reduction for cardiovascular health.
Key Mergers and Acquisitions:
✅ Tate & Lyle enhanced its global specialty ingredients portfolio through a major acquisition of assets focused on pectin and nature-based solutions, strengthening sustainable production capabilities in the functional food sector.
✅ Key players in the beta-glucan space pursued strategic expansions via mergers and capacity investments, targeting increased market share in high-demand regions like Asia Pacific.
✅ Leading beta-glucan producers consolidated positions with recent investments in production sites and partnerships for innovative plant-based technologies, aligning with rising health-driven demand.
Market Segmentation Analysis:
-By Source: Yeasts Lead with Proven Bioactivity
Yeasts dominate at 45% market share in 2024, prized for immune-boosting beta-glucans from baker's and brewer's strains used in functional foods and supplements.
Mushroom follows at 25%, valued for medicinal varieties like reishi enhancing immunity and cholesterol control.
Cereal holds 20%, sourced from oats and barley for soluble fiber in heart-healthy products.
Seaweed claims 10%, emerging for skin health applications despite extraction challenges.
-By Type: Soluble Prevails for Health Benefits
Soluble beta-glucan leads at 60%, excelling in cholesterol reduction, blood sugar control, and gut health via viscosity in foods and pharma.
Insoluble takes 40%, supporting immune modulation and wound healing in cosmetics and feeds.
-By Application: Food & Beverages Command Volume
Food & beverages capture 50% share, integrating beta-glucans into cereals, drinks, and bakery for fiber fortification and clean-label appeal.
Pharmaceuticals follow at 20%, targeting immune support and adjunct cancer therapy.
Personal care & cosmetics hold 15%, leveraging moisturizing and anti-aging properties.
Animal feed secures 10%, boosting livestock immunity and gut health.
Others account for 5%, in niche nutraceuticals.
Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=beta-glucan-market?ram (Purchase 2 or more Reports and get 50% Discount)
Why is the Beta-Glucan Market Growing?
-Rising Demand for Functional Foods and Nutraceuticals
Consumers increasingly seek natural ingredients for immune support, cholesterol reduction, and gut health, boosting beta-glucan's use in fortified foods like cereals, yogurts, and beverages.
This shift toward preventive healthcare and clean-label products aligns with growing awareness of beta-glucan's scientifically backed benefits for cardiovascular wellness and blood sugar regulation.
-Expansion in Pharmaceuticals and Personal Care
Beta-glucan's immunomodulatory properties drive its incorporation into supplements and drugs, while its skin-soothing and anti-aging effects enhance demand in cosmetics.
Advancements in extraction technologies improve scalability and cost-efficiency, broadening applications in animal feed and beyond.
-Health-Conscious Regional Growth
Asia-Pacific leads rapid adoption due to urbanization, dietary shifts toward wellness products, and rising middle-class spending on supplements.
North America and Europe maintain dominance through high awareness and established food processing, supported by government research incentives for dietary fibers.
Regional Insights:
-Europe leads the Beta-Glucan market with the highest regional share, around 36.6% as of recent data, driven by strong demand in food, beverages, and pharmaceuticals due to advanced processing industries and high consumer health awareness.
-North America follows closely with substantial dominance, capturing over 44% in earlier benchmarks and remaining a key market through robust nutraceutical consumption and innovation in dietary supplements.
-Asia Pacific registers rapid growth at a projected CAGR of 9.3%, fueled by urbanization, rising incomes in countries like China and India, and expanding health-conscious consumer bases, though its current share trails the leading regions.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/beta-glucan-market?ram
Key Players:
Biotec Pharmacon ASA | Biothera Pharmaceuticals, Inc. | Ceapro Inc. | Super Beta Glucan Inc. | DSM NV | Tate & Lyle Plc | AIT Ingredients | Shaanxi Undersun Biomedtech Co., Ltd. | Guangzhou Phytochem Sciences Inc. | Xi'an Best Bio-Tech Co., Ltd. | Shaanxi Yuantai Biological Technology Co., Ltd. | Wuling (Fuzhou) Biotechnology Co., Ltd. | among others
Key Highlights (Top 5 Key Players) for Beta-Glucan Market:
-Biotec Pharmacon ASA develops and manufactures high-purity beta-glucans from yeast and mushrooms for immune-modulating supplements, cosmetics, and wound care applications.
-Biothera Pharmaceuticals, Inc. produces Imprime PGG, a soluble yeast-derived beta-glucan that activates innate immune responses for cancer immunotherapy treatments.
-Ceapro Inc. extracts and commercializes beta-glucans from oats and barley for use in nutraceuticals, functional foods, and cosmeceuticals targeting skin health and cholesterol management.
-Super Beta Glucan Inc. supplies highly purified beta-1,3/1,6-glucan products from yeast sources, focusing on dietary supplements to enhance immune function and gut health.
-DSM NV offers beta-glucan ingredients from oats integrated into food, beverage, and health products to support heart health, satiety, and immune system benefits.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Beta-Glucan Market Set for Steady Growth at 7.05% CAGR Through 2031, Led by Europe's Dominant 36.6% Market Share | DataM Intelligence here
News-ID: 4338501 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
U.S. Alzheimer Drugs Market Set for Explosive Growth to USD 8.84 Billion by 2031 …
Leander Texas -
The Alzheimer Drugs Market reached US$ 4.46 billion in 2023 and is expected to reach US$ 18.33 billion by 2031, growing at a CAGR of 19.4% during the forecast period 2024-2031.
The Alzheimer's drugs market growth is driven by key US-Japan collaborations and approvals, including the JCR Pharma-Acumen Pharmaceuticals partnership to develop a novel blood-brain barrier Alzheimer therapy and expanded use of Eisai/Biogen's lecanemab with new subcutaneous application and…
Micro Nuclear Reactors (MNRs) Market to Reach US$ 4,865.85 Million by 2032 at 18 …
The Micro Nuclear Reactors (MNRs) Market reached US$ 1,434.55 million in 2024 and is projected to reach US$ 4,865.85 million by 2032, growing at a CAGR of 18.26 percent during the forecast period 2025 to 2032.
Market growth is driven by increasing demand for reliable, low-carbon energy solutions, supportive government policies promoting clean power generation, and the need for decentralized power in remote and industrial applications. Micro nuclear reactors offer scalable,…
Digital Identity Solutions Market Set for Explosive Growth to US$189.92 Billion …
The Global Digital Identity Solutions Market reached US$35.50 billion in 2023, with a rise to US$42.45 billion in 2024, and is expected to reach US$189.92 billion by 2033, growing at a CAGR of 20.45% during the forecast period 2025-2033.
Market growth is driven by escalating cybersecurity threats, surging demand for secure authentication in remote work and e-commerce, and widespread adoption of biometric and blockchain-based verification. Advancements in AI-powered fraud detection, expanding…
Iron Ore Mining Market Set for Strong Growth to USD 620.7 Billion by 2031, Led b …
Leander Texas -
Iron Ore Mining Market reached US$ 330.2 billion in 2022 and is expected to reach US$ 620.7 billion by 2031, growing with a CAGR of 8.2% during the forecast period 2024-2031.
The Iron Ore Mining Market's strong growth is boosted by rising infrastructure and steel demand in the U.S. and Japan, coupled with strategic developments like Japanese firms acquiring stakes in global iron ore assets and collaborations with U.S.…
More Releases for Beta
Beta-lactam and Beta-lactamase Inhibitors Market Emerging Trends and Growth Pros …
The global beta-lactam and beta-lactamase inhibitors market is valued at approximately $60 billion in 2024, driven by the rising prevalence of bacterial infections and the increasing resistance to traditional antibiotics. The market is projected to reach around $85 billion by 2034, reflecting a robust growth trajectory. This results in a Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period of 2025-2034.
Exactitude Consultancy., Ltd. released a research report…
Beta-Lactams & Beta-Lactamase Inhibitors: A Persistent Powerhouse in the Antibio …
The antibiotics market, despite facing challenges, remains a critical sector in global healthcare. Within this landscape, the Beta-Lactam and Beta-Lactamase Inhibitor segment stands out as a high-opportunity area, driven by the continued prevalence of bacterial infections and the ongoing fight against antimicrobial resistance (AMR).
Market Dynamics and Growth Drivers
Beta-lactam antibiotics, including penicillins and cephalosporins, have been the cornerstone of antibacterial therapy for decades. Their broad spectrum of activity and generally favorable…
apuem - beta
Today the beta phase of apuem starts. Our goal is to create the largest web app collection, and for that we need your help. So if you know a useful online tool that you like to use, suggest it to us. See more: apuem.com/suggestions We appreciate any kind of participation. Thank you very much!
Apuem
Finkenhofstraße 27
60322 Frankfurt am Main
Germany
Jacob Kearson
support@apuem.com
More Information: apuem.com/contact
We and our community search for the best web apps…
Beta-lactam and Beta-lactamase Inhibitors Market to Reach $34,170 Million by 202 …
Global beta-lactam and beta-lactamase inhibitors market size was $27,126 million in 2018, and is projected to reach $34,170 million by 2028, growing at a CAGR of 2.3% from 2019 to 2028. The cephalosporin segment accounted more than two-fifths of the total beta-lactam and beta-lactamase inhibitors market share in 2018.
Download Report Sample PDF @ https://www.alliedmarketresearch.com/request-sample/5427
Beta-lactam and beta-lactamase inhibitors are chemical compounds of natural or semi-synthetic or synthetic origin. They inhibit…
Beta-lactam and Beta-lactamase Inhibitors Market Outlook from 2019 to 2028
"According to a new report published titled, ""India Heat Exchangers Market by Type, Material of Construction, and End-User Industry: Opportunity Analysis and Industry Forecast, 2019-2026,"" the India heat exchangers market accounted for revenue of $454.4 million in 2018, and is anticipated to generate $890.0 million by 2026. The market is projected to grow at a CAGR of 8.6% from 2019 to 2026.
Heat exchangers are devices that transfer energy between fluids…
Beta-lactam and Beta-lactamase Inhibitors Market Size, Share, Development by 202 …
Global Info Research offers a latest published report on Beta-lactam and Beta-lactamase Inhibitors Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Beta-lactam and Beta-lactamase Inhibitors players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Beta-lactam and Beta-lactamase…
